Safety and antiviral activity of ANA598 in combination with pegylated interferon α2a plus ribavirin in treatment-naïve genotype-1 chronic HCV patients - Lawitz, E; Rodriquez-Torres, M; Rustgi, V; Hassanein, T
Paper presented at: The 48th Annual Meeting of the European Association for Study of the Liver Amsterdam; April 24–28, 2013; Amsterdam, The Netherlands